Zacks Research Has Weak Outlook for Revvity FY2025 Earnings

Revvity, Inc. (NYSE:RVTY) – Analysts at Zacks Research reduced their FY2025 earnings per share estimates for Revvity in a report released on Monday, April 14th. Zacks Research analyst R. Department now expects that the company will earn $4.94 per share for the year, down from their prior forecast of $4.95. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity’s Q1 2026 earnings at $1.10 EPS, Q2 2026 earnings at $1.34 EPS, FY2026 earnings at $5.45 EPS, Q1 2027 earnings at $1.29 EPS and FY2027 earnings at $6.18 EPS.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter last year, the business posted $1.25 earnings per share.

A number of other equities research analysts also recently weighed in on the company. Sanford C. Bernstein downgraded Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price for the company. in a report on Friday, January 10th. Raymond James reiterated an “outperform” rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research report on Monday, February 3rd. KeyCorp raised their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Barclays cut their price objective on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating on the stock in a research report on Thursday, April 10th. Four analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $133.75.

Revvity Stock Performance

Shares of RVTY opened at $95.54 on Wednesday. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41. The firm’s fifty day simple moving average is $108.15 and its two-hundred day simple moving average is $114.76. Revvity has a 12 month low of $89.61 and a 12 month high of $129.50. The stock has a market capitalization of $11.48 billion, a P/E ratio of 43.23, a price-to-earnings-growth ratio of 3.82 and a beta of 1.07.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of RVTY. Nissay Asset Management Corp Japan ADV boosted its holdings in shares of Revvity by 0.6% in the 4th quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company’s stock worth $1,682,000 after buying an additional 91 shares during the last quarter. Quarry LP boosted its stake in Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company’s stock valued at $34,000 after acquiring an additional 95 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Revvity by 2.4% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,214 shares of the company’s stock valued at $470,000 after acquiring an additional 100 shares during the period. HB Wealth Management LLC increased its stake in shares of Revvity by 4.6% during the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company’s stock worth $266,000 after purchasing an additional 104 shares during the last quarter. Finally, Signaturefd LLC lifted its stake in Revvity by 6.8% in the fourth quarter. Signaturefd LLC now owns 1,668 shares of the company’s stock valued at $186,000 after purchasing an additional 106 shares during the last quarter. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Insiders Place Their Bets

In other news, insider Joel S. Goldberg sold 15,170 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $126.73, for a total value of $1,922,494.10. Following the completion of the transaction, the insider now directly owns 33,400 shares of the company’s stock, valued at $4,232,782. This represents a 31.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.68% of the company’s stock.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.29%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s dividend payout ratio (DPR) is presently 12.67%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.